[ Price : $8.95]
FDA clears an Imbed Biosciences 510(k) for its Microlyte Ag/Lidocaine, an antimicrobial wound dressing that integrates lidocaine f...[ Price : $8.95]
AstraZeneca provides four comments to the FDA docket on considerations for generative artificial intelligence/machine learning ove...[ Price : $8.95]
GE HealthCare subsidiary Datex-Ohmeda recalls its Giraffe OmniBed and Giraffe OmniBed CareStation to update their use instructions...[ Price : $8.95]
UCB says its investigational Alzheimers drug bepranemab missed the primary endpoint in a Phase 2a trial but hit secondary endpoint...[ Price : $8.95]
Verastem Oncology completes a rolling NDA submission for the combination of avutometinib and defactinib for adults with recurrent ...[ Price : $8.95]
The DC federal court tosses a Jazz Pharmaceuticals suit against FDA over the agencys approval of Avadels narcolepsy drug Lumryz be...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled M13A Bioequivalence for Immediate-Release Solid Oral Dosage...[ Price : $8.95]
FDA accepts for review a Shanghai Henlius Biotech and Organon BLA for their biosimilar of Amgens Prolia/Xgeva (denosumab).